Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Davidson Kempner Capital Management Takes 6.5% Stake in ROI Acquisition Corp

Davidson Kempner Capital Management: Davidson Kempner, a hedge fund managed by Thomas Lenox Kempner, just disclosed ownership of almost 1.1 million shares of ROI Acquisition Corp II (NASDAQ:ROIQU), a filing with the SEC showed. In this way, the stake in ROI Acquisition Corp, which represents around 6.5% of the company, has a value of $11.9 millon, at the current price of company’s stock. This is a new addition to the equity portfolio of Davidson Kempner.

Roi acquisition Corp

ROI Acquisition Corp II is a blank check company. The company announced about its IPO on September 16, offering 12.5 million shares, at a price of $10 apiece. ROI Acquisition Corp II is involved in purchasing businesses with a focus on industries such as consumer products, retail and restaurants. Earlier this year, ROI Acquisition Corp. merged with EveryWare Global, Inc., a company specialized in consumer tabletop and foodservice markets.

Aside from ROI Acquisition Corp II, we should mention some other holdings in the equity portfolio of Davidson Kempner. As follows, the hedge fund holds a $54.5 million stake in Metlife Inc (NYSE:MET), which contains 1 million shares. Some other picks involve Sprint Corporation (NYSE:S), in which the hedge has a position worth $54.3 million, and Pfizer Inc. (NYSE:PFE), whose stake in Davidson Kempner Capital Management’s portfolio amounts to $50.3 million.

Recommended Reading:

Is Synageva BioPharma a Buy? Baker Bros. Thinks So

Greenway Medical Merger Agreement & One Hedge Fund’s Massive Stake

North Star Investment Management’s Latest Move In Universal Security

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!